Viela Bio to Webcast Fourth Quarter and Full Year 2019 Operating and Financial Results on March 25, 2020
GAITHERSBURG, Md., March 18, 2020 (GLOBE NEWSWIRE) -- Viela Bio (Nasdaq:VIE), a clinical-stage biotechnology company pioneering treatments for autoimmune and severe inflammatory disease, today announced it will host a webcast and conference call on Wednesday, March 25, 2020 at 5:00 p.m. ET to discuss its fourth quarter and full year 2019 operating and financial results.
The webcast will be accessible on the Events & Presentations page of the Company’s website. Individuals can participate in the conference call by dialing (877) 783-8848 (domestic) or (631) 350-0960 (international) and referring to conference ID #: 5057166. The archived webcast will be available for replay on the Viela Bio website approximately two hours after the event.
About Viela Bio
Viela Bio, headquartered in Gaithersburg, Maryland, is a clinical-stage biotechnology company dedicated to the discovery, development and commercialization of novel treatments for autoimmune and severe inflammatory diseases. For more information, please visit www.vielabio.com.
Source: Viela Bio
Contacts: Investors: Solebury Trout Chad Rubin 646-378-2947 firstname.lastname@example.org Media: Solebury Trout Amy Bonanno 914-450-0349 email@example.com